Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
STAA > SEC Filings for STAA > Form 8-K on 8-Apr-2013All Recent SEC Filings

Show all filings for STAAR SURGICAL CO | Request a Trial to NEW EDGAR Online Pro



Results of Operations and Financial Condition, Other Events, Financial Statemen

Item 2.02 Results of Operations and Financial Condition

On April 8, 2013, STAAR Surgical Company issued a News Release announcing its preliminary financial results for first quarter 2013. A copy of the News Release is furnished as Exhibit 99.1 to this current report.

Item 8.01 Other Events

On March, 26, 2013, STAAR Surgical Company (the "Company") filed a proxy statement (the "Proxy Statement") for its 2013 annual meeting of stockholders (the "Annual Meeting") to be held on May 13, 2013. The Proxy Statement included a proposal to approve the amendment and restatement of the Company's 2003 Omnibus Equity Incentive Plan to increase the number of shares of common stock available for issuance under that plan by 1,250,000 shares as well as additional revisions as described in Proposal No. 2 in the Proxy Statement.

The Company hereby supplements the information contained in its Proxy Statement by providing an evaluation of the weighted average of the contractual life of outstanding options, warrants and rights. The table below summarizes the additional disclosure about the outstanding options and shares of common stock that remain available for issuance under the Company's equity compensation plan as of March 15, 2013 (the record date).

                                                                                                      Number of
                                                                                   Weighted           Available
                                    Number of                                      Average           for Future
                                    Securities                  Weighted          Remaining           Issuance
                                   to be Issued                  Average         Contractual        under Equity
                                       Upon                     Exercise             Life           Compensation
                                   Exercise of                  Price of        of Outstanding          Plans
                                   Outstanding                 Outstanding         Options,          (excluding
                                     Options,                   Options,           Warrants          securities
                                   Warrants and               Warrants and        and Rights        reflected in
                                      Rights                   Rights ($)          (years)           column (a))
Plan Category                         (a)(1)                       (b)               (c)                 (d)
Equity Compensation Plans
Approved by Stockholders              3,957,613 (2)                    5.64               6.41             274,035

(1) As of March 15, 2013, the Company also had 309,500 shares of outstanding restricted stock which are not reflected in the table because they are treated as issued and outstanding and will not have additional dilutive impact on the Company when the awards vest.

(2) Consists of 3,831,613 option awards and 126,000 restricted stock unit awards.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

Exhibit No. Description
99.1 News Release, dated April 8, 2013, announcing STAAR Surgical Company's preliminary financial results for first quarter 2013.

  Add STAA to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for STAA - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now

Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.